VIVO
Index
Log in
Search form
Menu
Home
People
Organizations
Research
Events
A Phase 2 Study of Vx-950 in Combination With Peginterferon Alfa-2a (Pegasys)With & Without Ribavirin (Copegus) in .....
Grant
Overview
Affiliation
Identity
View All
Overview
date/time interval
June 1, 2006 - April 18, 2010
awarded by
Duke University
administered by
Gastroenterology, Hepatology, and Nutrition
total award amount
70778.25
direct costs
56622.20
sponsor award ID
VX05-950-104
local award ID
00060279
Affiliation
contributor
Nelson, David R
Principal Investigator
Identity
PeopleSoft Contract Number
00060279